| Metric | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥22.0B | ¥19.7B | +12.0% |
| Operating Income / Operating Profit | ¥3.0B | ¥2.3B | +30.0% |
| Ordinary Income | ¥3.1B | ¥2.3B | +35.5% |
| Net Income | ¥2.0B | ¥1.5B | +35.7% |
| ROE | 3.5% | 2.3% | - |
The results for 2027 FY Q1 were Revenue ¥22.0B (YoY +¥2.3B +12.0%), Operating Income ¥3.0B (YoY +¥0.7B +30.0%), Ordinary Income ¥3.1B (YoY +¥0.8B +35.5%), and Net Income attributable to owners of the parent ¥2.0B (YoY +¥0.4B +35.7%). In addition to double-digit top-line growth, gross margin improved to 54.3% (prior year 51.1%), a 3.2pt improvement, which expanded the operating margin to 13.8% (prior year 11.9%) by 1.9pt, resulting in revenue and profit growth. Non-operating items were immaterial so the difference between Ordinary Income and Operating Income was small; Special losses of ¥0.0B were recorded but had limited practical impact, confirming that profitability improvement was driven by core operations. Progress against the full year forecast was Revenue 21.0% and Operating Income 17.8%, below the standard 25%, suggesting seasonality and front-loaded investments.
[Revenue] Revenue was ¥22.0B, up +12.0% YoY. The Company operates a single segment (end-of-life services business) and segment-level breakdowns are not disclosed, but the top-line double-digit growth continues. Cost of sales was ¥10.1B, resulting in a cost of sales ratio of 45.7%, down 3.3pt from 49.0% a year earlier. As a result, gross profit was ¥12.0B (gross margin 54.3%), up ¥2.0B from ¥10.0B (gross margin 51.1%) in the prior year, with gross margin improving by 3.2pt. The gross margin improvement is presumed to be driven by a higher mix of higher-value-added services, price revisions, and improved monetization efficiency of the platform.
[Profitability] SG&A was ¥8.9B, up ¥1.2B YoY (+15.6%), growing faster than revenue (+12.0%). SG&A ratio rose to 40.5% from 39.2% a year earlier, indicating impact from front-loaded investments and strengthened hiring. However, the 3.2pt improvement in gross margin absorbed the SG&A ratio increase, yielding Operating Income of ¥3.0B (Operating margin 13.8%), up ¥0.7B from ¥2.3B (11.9%) a year earlier. Non-operating income was ¥0.1B (interest income ¥0.0B etc.) and non-operating expenses were ¥0.0B, both immaterial, resulting in Ordinary Income of ¥3.1B (YoY +35.5%). Although Special losses of ¥0.0B (e.g., loss on disposal of fixed assets) were recorded, profit before tax remained ¥3.1B and after corporate taxes of ¥1.1B (effective tax rate 34.8%), Net Income attributable to owners of the parent was ¥2.0B (YoY +35.7%). Net income attributable to non-controlling interests was ¥0.1B, and overall the company achieved revenue and profit growth.
[Profitability] Operating margin improved to 13.8% from 11.9% a year earlier (+1.9pt), and Net margin rose to 9.1% (prior year 7.9%) (+1.2pt). ROE remained at 3.5%; despite improved Net margin, low asset efficiency—Total Asset Turnover 0.30x (annualized 1.20x)—is a constraining factor. Financial leverage is conservative at 1.28x. [Cash Quality] Days Sales Outstanding (DSO) is prolonged at 208 days, indicating room to improve working capital efficiency. Inventories are ¥0.0B (negligible), and Cash Conversion Cycle (CCC) is long at 209 days. Accounts receivable balance is ¥12.6B, down from ¥13.4B a year earlier, showing some signs of collection improvement. [Investment Efficiency] Total Asset Turnover is low at 0.30x, and ample liquidity—Cash and deposits ¥34.9B (47.6% of total assets)—is depressing asset efficiency. Intangible fixed assets are ¥11.9B (16.2% of total assets) and goodwill is ¥2.3B (3.1%), so M&A-related impairment risk is limited. [Financial Soundness] Equity Ratio is 78.1% (prior year 75.1%), very robust; Current Ratio 402% and Quick Ratio 402% indicate no short-term liquidity concerns. Interest-bearing debt consists only of short-term borrowings of ¥0.5B, D/E ratio is 0.28x, and Net Cash is ¥34.4B, effectively debt-free. Retained earnings declined to ¥23.4B from ¥29.7B a year earlier, a decrease of ¥6.3B, suggesting prior-period shareholder returns or accounting reclassifications.
As the cash flow statement is not disclosed, funding trends were analyzed from balance sheet movements. Cash and deposits are ¥34.9B, down ¥7.1B from ¥42.0B a year earlier. This decrease may reflect shareholder returns such as prior dividends and share buybacks, or capital expenditures and working capital increases. Accounts receivable are ¥12.6B, down ¥0.8B from ¥13.4B a year earlier, indicating partial progress in collection processes. Meanwhile, items equivalent to advance receipts (deferred revenue etc.) were ¥1.5B, slightly up from ¥1.4B a year earlier, leaving room for expansion of subscription-type revenues. Inventories are negligible at ¥0.0B, implying limited cash tied up in inventory; work-in-progress is ¥0.0B, underscoring importance of project progress management. Accounts payable are ¥0.0B at a low level but up +27.9% YoY, potentially reflecting changes in payment terms or higher transaction volumes. Overall, abundant cash holdings ensure financial safety, while improving working capital efficiency (shortening DSO, increasing advance receipts) is key to increasing asset turnover and ROE.
This period’s profit improvement was driven at the Operating Income level, and non-operating income was ¥0.1B (0.5% of Revenue), indicating limited structural distortion. Non-operating expenses were also immaterial at ¥0.0B; dependence on non-recurring items such as interest income ¥0.0B or foreign exchange gains ¥0.0B is low. The gap between Ordinary Income ¥3.1B and Operating Income ¥3.0B is small, showing core profitability is sustained at the ordinary level. Special losses of ¥0.0B (e.g., loss on disposal of fixed assets) were one-off and had limited pre-tax impact. The effective tax rate of 34.8% is within normal range and indicates no tax anomalies. From an accrual perspective, prolonged DSO of 208 days and CCC of 209 days could introduce volatility to Operating Cash Flow and should be monitored. Comprehensive income was ¥2.0B, consistent with Net Income attributable to owners of the parent, with no uplift from Other Comprehensive Income. Overall, quality of earnings this period is backed by recurring earnings and is healthy.
The full year forecast remains Revenue ¥105.0B (prior year +26.0%), Operating Income ¥17.0B (prior year +46.3%), Ordinary Income ¥16.9B (prior year +45.0%), and Net Income attributable to owners of the parent ¥11.0B. Q1 progress rates are Revenue 21.0% (¥22.0B/¥105.0B), Operating Income 17.8% (¥3.0B/¥17.0B), Ordinary Income 18.4% (¥3.1B/¥16.9B), and Net Income 17.7% (¥1.95B/¥11.0B), all below the standard 25%. There is a 7.2pt negative deviation at the Operating Income level, which is likely due to seasonality (back-half weighting), front-loaded promotional and hiring investments, and timing lags in acceptance/collection. Recovery from Q2 onward (restoring progress to 50%) and confirmation of improvements in accounts receivable turnover and increases in advance receipts are keys to achieving the full year forecast.
The dividend forecast for the period is ¥0 per annum, same as the prior year, with a Payout Ratio of 0%. The company has ample financial capacity with Cash and deposits ¥34.9B and Equity Ratio 78.1%, so capacity for shareholder returns exists. The decline in retained earnings from ¥29.7B to ¥23.4B suggests large shareholder returns, such as dividends or share buybacks, in the prior period. ROE at 3.5% is below typical investor benchmarks; should capital efficiency improve (higher Total Asset Turnover, better working capital efficiency), the scope for resuming sustainable shareholder returns would expand.
Accounts receivable collection risk: DSO is prolonged at 208 days, creating risk of cash collection delays and realization of credit costs. Although accounts receivable decreased ¥0.8B YoY to ¥12.6B, it still represents approximately 57% of Revenue, and changes in customer payment capacity or collection terms could impact liquidity. Allowance for doubtful accounts of ¥0.2B has been recorded, but deterioration in the economy or customer mix may require additional allowances.
Working capital efficiency deterioration risk: CCC is long at 209 days, and working capital tie-up increases the volatility of operating cash flows. The existence of work-in-progress at ¥0.0B suggests complexity in project progress management; delays in acceptance or project prolongation could shift revenue recognition and cash flow timing. If expansion of advance receipts or transition to subscription-type revenues does not progress, improvement in cash conversion will be delayed.
Profit pressure from SG&A increases: SG&A rose +15.6% YoY, outpacing revenue growth of +12.0%, reflecting ongoing front-loaded investments. While gross margin improvement currently absorbs this, if price competition intensifies or the mix of high-value services declines, gross margin deterioration could compress operating margin. Concentration in a single segment (end-of-life services) carries vulnerability to demand fluctuations and competitive pressure.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating margin | 13.8% | 8.0% (2.2%–15.8%) | +5.7pt |
| Net margin | 9.1% | 5.8% (1.5%–10.7%) | +3.4pt |
Profitability significantly exceeds the industry median, and Operating margin is within the top 25%.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (YoY) | 12.0% | 9.3% (0.2%–16.9%) | +2.7pt |
Revenue growth exceeds the industry median, placing growth from mid- to upper-range.
※ Source: Company compilation
Continued profitability improvement driven by gross margin enhancement; Operating margin 13.8% is 5.7pt above the industry median. Expansion of higher-value-added services and price revisions have been effective and form a base for sustained margin improvement. However, SG&A growth outpacing revenue warrants attention to the sustainability of operating leverage and the need to restrain SG&A ratio.
Progress against the full year forecast is below the standard 25% at the Operating Income level (17.8%), making a rebound from Q2 onward essential. While seasonality and front-loaded investments should be factored in, prolonged DSO (208 days) and CCC (209 days) indicate substantial room for working capital efficiency improvement. Shortening receivable collection, expanding advance receipts, and shifting to subscription-based revenues would boost Total Asset Turnover and improve ROE.
Financial position is extremely solid, maintaining an Equity Ratio of 78.1% and Net Cash of ¥34.4B with effectively no debt. The YoY decline in retained earnings may reflect prior shareholder returns; should profit accumulation and capital efficiency improvements occur this period, the potential for resuming shareholder returns would expand. Improving Total Asset Turnover (currently 0.30x) — a constraint on ROE 3.5% — will be key to investor re-rating.
This report was automatically generated by AI analyzing XBRL financial statement data. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company based on public financial statement data. Investment decisions should be made at your own responsibility and, where necessary, in consultation with a professional advisor.